Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
299.4 USD | +0.52% | -3.44% | +5.56% |
30/04 | ICON Prices $2 Billion Debt Offering | MT |
26/04 | UBS Adjusts ICON Price Target to $380 From $368, Maintains Buy Rating | MT |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
24.63B | ||||||
42.19B | ||||||
40.15B | ||||||
28.31B | ||||||
18.2B | - | |||||
12.01B |